ecancermedicalscience

Special Issue

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

29 Apr 2015
Domenico Mattoscio, Chiara Casadio, Marzia Fumagalli, Mario Sideri, Susanna Chiocca

Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

Article metrics: 1004 views
312
692

Related Articles

Ryan M Kahn, Sushmita Gordhandas, Kiersten Craig, Tanaka K Dune, Kevin Holcomb, Eloise Chapman-Davis, Melissa K Frey
Julia Ismael, Federico Losco, Sergio Quildrian, Pablo Sanchez, Isabel Pincemin, Jose Lastiri, Santiago Bella, Alejandro Chinellato, Guillermo Dellamea, Alejandro Ahualli, Silvana Rompato, Julio Velez, Rafael Escobar, Ariel Zwenger, Cristina Rosales, Claudia Bagnes, Jorge Puyol, Dario Niewiadomski, Edgardo Smecuol, Fabio Nachman, Eduardo Gonzalez, Gustavo Ferraris, Juan Ramos Suppicich, Paola Price, Luis Medina, Juan O’Connor
Milan Terzic, Melanie Norton, Sanja Terzic, Gauri Bapayeva, Gulzhanat Aimagambetova
Mattia Maramai, Fabio Barra, Mario Valenzano Menada, Sara Stigliani, Melita Moioli, Sergio Costantini, Simone Ferrero
Barbara Buonomo, Roberto Orecchia, Federica Tomao, Lino Del Pup, Alex Garcia-Faura, Fedro A Peccatori